All the buzz today is specialty. Everything seems to be special. There …
CMS Guidance 2018: Managing Part B Drugs (Part 3)
Part 2 of our 3 part series on the new CMS guidance …
CMS Guidance 2018: Managing Part B Drugs (Part 2)
Part 1 of our 3 part series on the new CMS guidance …
NTMB – A Dreaded 4-Letter “Word”
The “New-to-Market-Block” – NTMB – yikes. No manufacturer, who has spent years …
CMS Guidance 2018: Managing Part B Drugs (Part 1)
In 2012, CMS published guidance which prohibited mandatory step therapy for Part …
The Complex World of Medicaid… Are You Ready?
Many products drive most of their business through the Commercial channel. But …
We Are Stewards Of The Resources
I heard this phrase during a presentation on rare/orphan diseases at the …
A Changing Landscape
It is cliché to say that the only constant is change. It …
The Trends That Keep On Trending
One of the biggest buzz phrases today is “trending now”. We see …
3 Things Every Market Access Strategy Should Be
A viable, well-executed market access strategy for a new pharmaceutical launch is …